← Open Payments lookup

MARY HNEICH: Open Payments

NPI 1669753810 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,333 in 203 payments from 13 companies in 2025. Trend: 2023 $3,682 · 2024 $3,431 · 2025 $4,333

Food & beverage: $4,118Education: $215
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.26$880
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)38$849
Alkermes, Inc.23$516
Otsuka America Pharmaceutical, Inc.26$448
Teva Pharmaceuticals USA, Inc.17$432
Vanda Pharmaceuticals Inc.13$332
E.R. Squibb & Sons, L.L.C.29$313
Lundbeck LLC13$211
Axsome Therapeutics, Inc.6$125
Janssen Pharmaceuticals, Inc5$113

Products named: INGREZZA, CAPLYTA, REXULTI, ARISTADA, FANAPT, COBENFY, UZEDY, ABILIFY ASIMTUFII.

Industry payments across AL — which companies pay providers there.